Steven Cohen Point72 Asset Management
Steven Cohen is the founder of Point72 Asset Management and previously built SAC Capital into one of the industry’s most profitable trading firms. Point72 operates a multi-manager platform combining fundamental long/short equity with systematic and other strategies. Cohen is also a major figure in sports ownership and philanthropy, while remaining one of the most closely followed names in hedge fund trading culture.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$254M |
| 2 |
Marvell Technology
MRVL
|
+$248M |
| 3 |
Fidelity National Information Services
FIS
|
+$198M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$176M |
| 5 |
Elevance Health
ELV
|
+$161M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FDC
First Data Corporation
FDC
|
+$224M |
| 2 |
Baxter International
BAX
|
+$223M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$221M |
| 4 |
Visa
V
|
+$218M |
| 5 |
Citigroup
C
|
+$189M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.5% |
| 2 | Healthcare | 13.29% |
| 3 | Consumer Discretionary | 11.89% |
| 4 | Energy | 9.85% |
| 5 | Communication Services | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Incyte
INCY
$25.9B
| $6.56M | 0.03% |
76,239
+1,778
| +2% | +$145K |
|
|
APLS
502
DELISTED
Apellis Pharmaceuticals
APLS
| $6.51M | 0.03% |
333,629
+222,613
| +201% | +$3.5M |
|
|
ZUO
503
DELISTED
Zuora, Inc.
ZUO
| $6.49M | 0.03% |
324,032
+218,632
| +207% | +$4.72M |
|
504
PUT
Adient
ADNT
$1.54B
| $6.48M | 0.03% |
+500,000
| New | +$8.75M |
|
505
Kroger
KR
$35.5B
| $6.48M | 0.03% |
+263,370
| New | +$7.22M |
|
506
Waste Management
WM
$89.6B
| $6.48M | 0.03% |
+62,332
| New | +$6.08M |
|
507
Criteo S.A.
CRTO
$855M
| $6.46M | 0.03% |
+322,601
| New | +$8.22M |
|
508
Popular Inc
BPOP
$10.8B
| $6.44M | 0.03% |
123,478
-252,222
| -67% | -$13.4M |
|
509
Cushman & Wakefield Ltd
CWK
$3.48B
| $6.43M | 0.03% |
+361,529
| New | +$6.23M |
|
510
Magna International
MGA
$19.5B
| $6.43M | 0.03% |
132,100
-15,000
| -10% | -$756K |
|
|
MNDT
511
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $6.41M | 0.03% |
381,821
-3,414,924
| -90% | -$57.5M |
|
512
SLM Corp
SLM
$4.97B
| $6.4M | 0.03% |
645,500
-2,010,500
| -76% | -$20.8M |
|
513
argenx
ARGX
$65B
| $6.24M | 0.03% |
50,000
-7,900
| -14% | -$929K |
|
514
Rio Tinto
RIO
$171B
| $6.22M | 0.03% |
105,670
-474,074
| -82% | -$26.1M |
|
|
ATH
515
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $6.21M | 0.03% |
152,180
-244,438
| -62% | -$10.5M |
|
516
KB Home
KBH
$3.39B
| $6.13M | 0.03% |
+253,509
| New | +$5.62M |
|
517
Arvinas
ARVN
$613M
| $6.13M | 0.03% |
+415,000
| New | +$7.36M |
|
518
InflaRx
IFRX
$309M
| $6.12M | 0.03% |
161,913
+109,190
| +207% | +$4.07M |
|
519
ENI
E
$81.5B
| $6.08M | 0.03% |
172,559
-141,132
| -45% | -$4.79M |
|
520
Travere Therapeutics
TVTX
$6.19B
| $6.02M | 0.03% |
266,100
-433,900
| -62% | -$9.59M |
|
521
Zscaler
ZS
$29.4B
| $6.02M | 0.03% |
+84,900
| New | +$4.51M |
|
522
PUT
uniQure
QURE
$3.36B
| $5.96M | 0.03% |
+100,000
| New | +$4.47M |
|
|
PDCO
523
DELISTED
Patterson Companies, Inc.
PDCO
| $5.96M | 0.03% |
272,979
-107,361
| -28% | -$2.38M |
|
524
CALL
DexCom
DXCM
$34.8B
| $5.96M | 0.03% |
+200,000
| New | +$7.03M |
|
|
ALBO
525
DELISTED
Albireo Pharma Inc
ALBO
| $5.91M | 0.03% |
183,495
+169,795
| +1,239% | +$4.57M |
|
Similar funds
Steven Cohen's Q1 2019 Portfolio in Review
As of Q1 2019, Steven Cohen held 1,362 positions worth $22B, up 7.6% from $20.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Steven Cohen withdrew a net $1.52B in Q1 2019, closing 372 positions and reducing 305 holdings. Its most notable exit was Baxter International, an estimated $223M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 9.6% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Steven Cohen opened a new position in Fidelity National Information Services worth $210M.
- Steven Cohen's largest Q1 2019 buy was Fidelity National Information Services: 1,858,246 shares worth $210M.
- Steven Cohen added most to Walt Disney in Q1 2019, an estimated $254M increase.
- Steven Cohen's biggest Q1 2019 reduction was First Data Corporation, cutting an estimated $224M.
- Steven Cohen fully exited Baxter International in Q1 2019, selling an estimated $223M.
- Steven Cohen's ten largest holdings make up 18% of its $22B portfolio in Q1 2019.
- Steven Cohen opened 440 new positions and closed 372 in Q1 2019.
- Steven Cohen's portfolio value rose 7.6% quarter-over-quarter to $22B.
Based on Point72 Asset Management's 13F filing for Q1 2019, filed 15 May 2019.